Prev Arrow Stocks

Chemours Company (The) ($CC) Stock Forecast: Up 5.1% Today

Morpher AI identified a bullish signal. The stock price may continue to rise based on the momentum of the good news.

What is Chemours Company (The)?

Chemours (NYSE: CC) is a chemical company that has recently experienced a strong bullish movement in the stock market.

Why is Chemours Company (The) going up?

CC stock is up 5.1% on Apr 16, 2026 17:36

  • Chemours (CC) reached a new 52-week high of $23.20, trading with high volume and significantly above its moving averages, reflecting robust investor interest and positive market sentiment.
  • The increase in Chemours' stock price can be linked to the company's recent strong financial performance, surpassing EPS expectations, despite having certain mixed fundamentals like negative net margin and P/E ratio.
  • The update about Southeast Ohio water authorities securing funds for PFAS treatment upgrades may have had a positive impact on Chemours, given the company's involvement in producing chemicals and solutions relevant for water treatment processes.
  • Despite being labeled as overvalued by some analysts, there appears to be a positive market outlook on Chemours' future prospects, with institutions like UBS raising their price target and reaffirming a "Buy" rating.

CC Price Chart

CC Technical Analysis

CC News

Chemours (NYSE:CC) Sets New 1-Year High - Should You Buy?

Chemours (NYSE:CC) recently hit a new 52-week high of $23.20, trading on strong volume and well above its moving averages. While analyst sentiment is mixed with an average "Hold" rating and $20.40 price target, UBS recently raised its target to $29 and reiterated a "Buy." The company's fundamentals currently show mixed results, including beating EPS expectations but having negative net margin and P/E, alongside a 1.5% dividend yield.

https://www.marketbeat.com/instant-alerts/chemours-nysecc-sets-new-1-year-high-should-you-buy-2026-04-14/

0 News Article Image Chemours (NYSE:CC) Sets New 1-Year High - Should You Buy?

Southeast Ohio water authorities receive millions for PFAS treatment upgrades

Water authorities across Southeast Ohio are receiving $65 million from a 2023 settlement with DuPont to upgrade their treatment technology for PFAS chemicals. Six water authorities in Washington County alone are getting between $2 million and over $8 million for projects like installing waterline extensions, adding PFAS treatment to plants, and constructing new facilities. Similar funding is also distributed to water authorities in Belmont, Gallia, Lawrence, Meigs, and Morgan counties to mitigate PFAS contamination and provide safer drinking water to thousands of residents.

https://www.wtap.com/2026/04/13/southeast-ohio-water-authorities-receive-millions-pfas-treatment-upgrades/

1 News Article Image Southeast Ohio water authorities receive millions for PFAS treatment upgrades

A Look At Chemours (CC) Valuation After Its Recent Share Price Surge

Chemours (CC) has seen a significant share price surge recently, with gains of 29.25% in one month and 85.39% year-to-date, contrasting with a 14.69% decline over three years. Despite this rally, the company is estimated to be 39% overvalued with a fair value of $16.33, according to a detailed cash flow analysis that considers progress in resolving PFAS litigation risks. However, a simpler P/S ratio comparison suggests Chemours trades at a discount compared to its industry, potentially leaving room for rerating.

https://simplywall.st/stocks/us/materials/nyse-cc/chemours/news/a-look-at-chemours-cc-valuation-after-its-recent-share-price

2 News Article Image A Look At Chemours (CC) Valuation After Its Recent Share Price Surge

The Chemours Co (HAM:2CU) Stock Holders - Institutional & Insider Ownership

This article from GuruFocus analyzes the institutional and insider ownership of The Chemours Co (HAM:2CU). It provides historical data for both types of ownership, noting that GuruFocus short interest data is no longer updated for most stocks. The article highlights considerations from investors like Peter Lynch regarding institutional ownership and the alignment of interests with insider ownership.

https://www.gurufocus.com/stock/HAM:2CU/ownership

3 Missing News Article Image The Chemours Co (HAM:2CU) Stock Holders - Institutional & Insider Ownership

The Chemours Company $CC Shares Sold by Twelve Points Wealth Management LLC

Twelve Points Wealth Management LLC reduced its stake in The Chemours Company (NYSE:CC) by 40.6% in the fourth quarter, selling 50,364 shares and now holding 73,609 shares valued at $868,000. Despite this reduction, other institutions like SG Americas Securities LLC significantly increased their holdings, and overall institutional ownership stands at 76.26%. Chemours reported strong Q4 EPS, beating analyst estimates, and maintains a consensus "Hold" rating with a target price of $20.40.

https://www.marketbeat.com/instant-alerts/filing-the-chemours-company-cc-shares-sold-by-twelve-points-wealth-management-llc-2026-04-11/

4 News Article Image The Chemours Company $CC Shares Sold by Twelve Points Wealth Management LLC

Chemours Company (The) Price History

10.03.2026 - CC Stock was up 5.4%

  • Chemours (CC) experienced a strong bullish movement today due to an increased target price and maintained Buy rating by a leading financial institution. This positive outlook reflects confidence in the company's growth potential.
  • The high-performance fluoropolymers (HPF) market is projected to grow, potentially benefiting Chemours given its presence in industrial chemicals, including components for aerospace and automotive industries.
  • Despite the positive forecast and price target increase, Chemours reported a negative net margin and a year-over-year revenue decline, suggesting possible challenges ahead despite the bullish market movement.
  • Ongoing discussions by the EU chemicals agency regarding PFAS chemicals could have implications for Chemours in the future, underscoring regulatory risks in the industry.

30.02.2026 - CC Stock was down 5.1%

  • Despite a recent 5-day winning streak and reaching a new 52-week high, Chemours stock showed strong bearish movement today.
  • Investor profit-taking following the stock's surge in the past few days could explain the bearish pullback.
  • Concerns from analysts regarding the company's weak operational performance, financial state, and high valuation might have influenced the bearish sentiment.
  • The absence of specific positive developments today likely prompted investors to reassess their positions, resulting in the bearish market trend.

16.03.2026 - CC Stock was up 5.1%

  • Chemours (CC) reached a new 52-week high of $23.20, trading with high volume and significantly above its moving averages, reflecting robust investor interest and positive market sentiment.
  • The increase in Chemours' stock price can be linked to the company's recent strong financial performance, surpassing EPS expectations, despite having certain mixed fundamentals like negative net margin and P/E ratio.
  • The update about Southeast Ohio water authorities securing funds for PFAS treatment upgrades may have had a positive impact on Chemours, given the company's involvement in producing chemicals and solutions relevant for water treatment processes.
  • Despite being labeled as overvalued by some analysts, there appears to be a positive market outlook on Chemours' future prospects, with institutions like UBS raising their price target and reaffirming a "Buy" rating.

20.02.2026 - CC Stock was down 5.0%

  • Today's downward trend in CC's stock price could be linked to an investigation initiated by the Portnoy Law Firm into potential securities fraud, triggered by disappointing financial results in Q4 and full-year 2025. This development possibly eroded investor confidence, resulting in the stock decline.
  • The Brunswick County Board of Commissioners' unanimous disapproval of Chemours' proposed expansion due to worries about PFAS contamination in the Cape Fear River watershed might have exacerbated negative investor sentiment, contributing to the bearish movement.
  • Despite the adverse updates, the recent intraday stock price increase of 7.65% and a subsequent 9.4% rise following analysts' heightened price targets indicate some positive market sentiment. Nevertheless, enduring challenges like a high debt-to-equity ratio and negative return on equity are persisting factors impacting the stock's performance.

08.03.2026 - CC Stock was down 5.8%

  • The bearish movement in CC's stock today could be attributed to concerns surrounding the ongoing lawsuit with the Cape Fear Public Utility Authority over PFAS contamination in drinking water.
  • Despite a company raising its price target on CC and maintaining an "Outperform" rating, the market may be reacting to uncertainties regarding the impact of ultrashort-chain PFAS compounds on the company's operations.
  • The upsizing and pricing of the $700 million senior notes offering by Chemours could have also influenced the bearish sentiment, as investors may be wary of the company's increased debt burden.
  • The significant increase in stake by SG Americas Securities LLC signals long-term confidence in Chemours, but the market may be focusing more on the immediate challenges the company is facing with regards to environmental issues and financial decisions.

19.02.2026 - CC Stock was down 5.6%

  • Today's significant bearish movement in CC's stock might be related to investors having a negative reaction towards the company's cautious capital allocation approach. This was highlighted by a debt refinance with higher coupon rates, an increase in CEO pay, and a dividend cut.
  • Concerns have been raised among investors due to long-term challenges like a high debt-to-equity ratio and negative return on equity, which could have led to the stock sell-off.
  • Although there has been positive short-term performance and an earnings beat as of late, investor sentiment may be impacted by ongoing PFAS liabilities and market risks, ultimately contributing to today's bearish market movement.

26.02.2026 - CC Stock was up 5.1%

  • Chemours' stock price surged by 10.11% following the completion of a successful debt swap, indicating investor confidence in the company's financial stability and growth prospects.
  • The strategic agreement with SRF Limited to boost the supply of key low GWP products highlights Chemours' commitment to sustainability and meeting market demand, which likely contributed to the positive market sentiment.
  • Despite facing challenges such as high debt levels and legal battles, Chemours' focus on next-generation refrigerants and environmental regulations positions it well for future growth in the chemical industry.
  • The company's engagement in STEM education initiatives showcases its dedication to fostering talent and innovation, creating a positive image that resonates with investors and stakeholders.

09.03.2026 - CC Stock was up 5.6%

  • CC reached a 52-week high at $22.56, marking a 139% increase in the past year, potentially attracting positivity from investors.
  • Mizuho raised CC's price target to $25 from $21, upholding an "Outperform" rating, potentially enhancing investor confidence and influencing the bullish trend.
  • Despite the lawsuit and regulatory challenges, CC's optimistic earnings forecast for 2026 and expected improvements in titanium dioxide EBITDA margins may have outweighed these issues, propelling the stock.
  • The options chain analysis, detailing call and put options expiring in May 2026, possibly signified a bullish outlook among traders, adding momentum to CC's stock.

25.02.2026 - CC Stock was up 5.1%

  • A successful $700 million debt refinancing and insider buying activities have eased financial concerns, fostering a favorable investor sentiment.
  • Price target upgrades from various firms, including UBS and Mizuho, have been influenced by robust quarterly earnings within the specialized solutions segment, contributing to the uptrend in the stock.
  • Despite potential challenges like regulatory scrutiny regarding environmental issues such as PFAS liabilities, Chemours' strategic outlook remains promising due to continuous innovation efforts and substantial order backlogs.
  • An investigation by The Portnoy Law Firm subsequent to disappointing Q4 and full-year 2025 financial results may have initially dampened investor confidence; however, positive developments thereafter appear to have reversed the stock's trajectory.

24.02.2026 - CC Stock was up 6.1%

  • The bullish movement in CC's stock can be attributed to the successful $700 million private sale of senior notes and insider buying, which helped alleviate financial concerns and boost investor confidence.
  • Analyst upgrades and positive outlook on the company's strategic direction, particularly in the thermal and specialized solutions segment, have also contributed to the stock surge.
  • Despite ongoing legal challenges and environmental controversies, including the lawsuit against DuPont and Chemours and opposition to the Fayetteville expansion, the market seems to be focusing more on the company-specific improvements and growth prospects, leading to the bullish momentum in CC's stock.

23.02.2026 - CC Stock was up 5.0%

  • The North Carolina Supreme Court reviewing a lawsuit against DuPont and Chemours may have introduced legal uncertainties and risks for the company, impacting market sentiment initially.
  • An investigation into potential securities fraud by the Portnoy Law Firm following disappointing financial results likely contributed to CC's stock price decline.
  • The subsequent increase in CC's stock price may be linked to three analyst firms raising their price targets for the company, indicating improved sentiment and potentially attracting more institutional investors.
  • The strong intraday surge and outperformance of the S&P 500 suggest a positive short-term market response to the raised price targets and overall analyst enthusiasm, despite CC's enduring financial challenges and environmental issues.

01.03.2026 - CC Stock was down 5.0%

  • The bearish movement in Chemours stock today could be attributed to profit-taking by investors after the recent 5-day winning spree, where the stock climbed 22%.
  • Concerns may have arisen among investors about potential legal liabilities and future financial impacts on the company due to the news about a potential new lawsuit against Chemours for PFAS contamination in North Carolina.
  • Despite the positive collaboration with the University of Kansas on sustainable cooling technologies, the overall sentiment from analysts describing the stock as "Very Unattractive" due to weak operating performance and high valuation could have also influenced today's bearish market movement.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.